DEF 14C: BioAdaptives Stockholders Approve Increase in Authorized Shares

BioAdaptives stockholders have approved an amendment to the company's certificate of incorporation to increase the number of authorized common and preferred shares.

Summary

• BioAdaptives, Inc. is providing notice to its stockholders regarding an action approved by written consent of holders of a majority of the company's outstanding voting stock.
• The action involves an amendment to the company's Certificate of Incorporation (ACOI).
• The ACOI increases the authorized shares of common stock from an unspecified amount to 1,250,000,000 shares, with a par value of $0.0001 per share.
• It also increases the number of authorized preferred shares from 10,000,000 to 31,000,000, with a par value of $0.0001 per share.
• The written consent received constitutes the only stockholder approval required under Delaware law and the company's governing documents.
• The action was effective as of March 27, 2025.
• Stockholders are not being asked to provide consent or proxies.
• The record date for determining stockholders entitled to notice was February 20, 2025.
• As of the record date, 8,211,526 shares of common stock were outstanding and entitled to take action by written consent and to receive notice of the action taken by the Written Consent.
• As of the record date, a total of 102,471,651 votes, comprised of votes associated with common and preferred shares were cast in favor of the amendment, consenting thereto.

Sentiment

Score: 6

Explanation: The document is a standard corporate notification. The increase in authorized shares is generally neutral, providing flexibility but also potentially diluting existing shareholders if shares are issued.

Positives

• The increase in authorized shares provides the company with greater flexibility for future financing, acquisitions, and incentive plans.
• The company has secured the necessary stockholder approval for the amendment.

Future Outlook

The company intends to use the increased authorized shares for potential debt conversions, acquisitions, capital asset exchanges, incentive plans, and possible offerings.

Management Comments

• The Company is increasing the preferred number of its shares to provide it capability to issue preferred shares in the event of a conversion of existing and anticipated debt obligations, to provide additional capabilities to issue shares in exchange for capital assets or in acquisitions, for purposes of any Incentive Plan adopted by the board, and in the event of a possible offering.

Industry Context

Companies often increase their authorized share capital to provide flexibility for future corporate actions, such as raising capital, making acquisitions, or implementing stock-based compensation plans. This is a fairly standard corporate practice.

Stakeholder Impact

• Existing shareholders may experience dilution if the newly authorized shares are issued.
• The increased flexibility could benefit the company and its stakeholders in the long term if it enables strategic acquisitions or capital raising.

Key Dates

Keywords

authorized shares, common stock, preferred stock, certificate of incorporation, BioAdaptives, stockholders